Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Dare Bioscience (DARE) Shares Issued (2016 - 2024)

Dare Bioscience's Shares Issued history spans 10 years, with the latest figure at $453579.0 for Q4 2024.

For Q4 2024, Shares Issued rose 45357800.0% year-over-year to $453579.0; the TTM value through Dec 2024 reached $453579.0, down 65.09%, while the annual FY2025 figure was $20.9 million, 4514.44% up from the prior year.
Shares Issued reached $453579.0 in Q4 2024 per DARE's latest filing, up from $1.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $36.2 million in Q3 2021 to a low of -$120149.0 in Q3 2022.
Average Shares Issued over 5 years is $4.3 million, with a median of $453579.0 recorded in 2024.
Peak YoY movement for Shares Issued: tumbled 100.33% in 2022, then soared 45357800.0% in 2024.
A 5-year view of Shares Issued shows it stood at $1.8 million in 2020, then plummeted by 86.27% to $245280.0 in 2021, then tumbled by 148.98% to -$120149.0 in 2022, then soared by 100.0% to $1.0 in 2023, then skyrocketed by 45357800.0% to $453579.0 in 2024.
Per Business Quant, the three most recent readings for DARE's Shares Issued are $453579.0 (Q4 2024), $1.0 (Q4 2023), and $1.3 million (Q1 2023).